CSO/VP
- Samantha Wein
- Apr 3
- 1 min read
Updated: Apr 24
We're currently representing a Senior Vice President-level Scientific Leader with deep experience in advancing innovative platforms and therapies from target identification through successful regulatory submission.
This leader has overseen:
• Research & Development Strategy: Multi-program oversight for ADCs and biologics.
• Therapeutic Expertise: Deep focus in biology of genetic diseases.
• Regulatory Submissions: Driven writing and successful filing of regulatory documents.
• External Strategy: Management of collaborations, IP portfolio development, and publication strategy.
• Investor & Board Relations: Extensive experience representing scientific platforms to VCs, institutional investors, and regulatory authorities. Lead scientific strategy to support financing efforts totaling ~$550M (Private and Public/IPO).
Career highlights include:
✔ Scientific Architect of drug delivery platform currently in clinical stages.
✔ Strategic portfolio expansion across neurology, hematology, and musculoskeletal areas.
✔ Key Opinion Leader (KOL) Engagement: Established global networks of experts to validate pre-clinical research.
✔ Inventor on 12+ patents regarding novel delivery complexes and dosing formulations.
✔ Invited speaker and chair at 30+ international scientific conferences and summits.
This is a high-impact, investor-facing scientific executive—expert at de-risking complex science and articulating technical value to the capital markets.
Ideal for: Chief Scientific Officer (CSO) / Chief Scientific Liaison / Executive VP of Research roles within venture-backed startups or platform-stage biotechs where the focus is on scientific strategy, IP building, and investor engagement.
Discreet inquiries welcomed. If your organization needs a heavyweight scientific presence to lead your next financing round, de-risk your platform, or drive your research strategy—let’s connect.
Interested in this candidate? To request a resume or schedule an interview, please book a consultation with our team or contact us directly using the links below.
Comments